182 related articles for article (PubMed ID: 38062491)
1. An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma.
El-Husseini ZW; Khalenkow D; Lan A; van der Molen T; Brightling C; Papi A; Rabe KF; Siddiqui S; Singh D; Kraft M; Beghe B; van den Berge M; van Gosliga D; Nawijn MC; Rose-John S; Koppelman GH; Gosens R
Respir Res; 2023 Dec; 24(1):308. PubMed ID: 38062491
[TBL] [Abstract][Full Text] [Related]
2. Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation.
Jevnikar Z; Östling J; Ax E; Calvén J; Thörn K; Israelsson E; Öberg L; Singhania A; Lau LCK; Wilson SJ; Ward JA; Chauhan A; Sousa AR; De Meulder B; Loza MJ; Baribaud F; Sterk PJ; Chung KF; Sun K; Guo Y; Adcock IM; Payne D; Dahlen B; Chanez P; Shaw DE; Krug N; Hohlfeld JM; Sandström T; Djukanovic R; James A; Hinks TSC; Howarth PH; Vaarala O; van Geest M; Olsson H;
J Allergy Clin Immunol; 2019 Feb; 143(2):577-590. PubMed ID: 29902480
[TBL] [Abstract][Full Text] [Related]
3. Increased IL-6 and Potential IL-6 trans-signalling in the airways after an allergen challenge.
Esnault S; Khosravi M; Kelly EA; Liu LY; Bochkov YA; Tattersall MC; Jarjour NN
Clin Exp Allergy; 2021 Apr; 51(4):564-573. PubMed ID: 33471392
[TBL] [Abstract][Full Text] [Related]
4. Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling.
Cho SH; Kim DW; Lee SH; Kolliputi N; Hong SJ; Suh L; Norton J; Hulse KE; Seshadri S; Conley DB; Kern RC; Tan BK; Peters A; Grammer LC; Schleimer RP
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):601-6. PubMed ID: 26266960
[TBL] [Abstract][Full Text] [Related]
5. Effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle.
Ammit AJ; Moir LM; Oliver BG; Hughes JM; Alkhouri H; Ge Q; Burgess JK; Black JL; Roth M
Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L199-206. PubMed ID: 16936245
[TBL] [Abstract][Full Text] [Related]
6. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model.
Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS
J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396
[TBL] [Abstract][Full Text] [Related]
7. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
[TBL] [Abstract][Full Text] [Related]
8. Allergen-induced IL-6 trans-signaling activates γδ T cells to promote type 2 and type 17 airway inflammation.
Ullah MA; Revez JA; Loh Z; Simpson J; Zhang V; Bain L; Varelias A; Rose-John S; Blumenthal A; Smyth MJ; Hill GR; Sukkar MB; Ferreira MA; Phipps S
J Allergy Clin Immunol; 2015 Oct; 136(4):1065-73. PubMed ID: 25930193
[TBL] [Abstract][Full Text] [Related]
9. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
Hashizume M; Mihara M
Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703
[TBL] [Abstract][Full Text] [Related]
10. High-dose glucocorticoids increase serum levels of soluble IL-6 receptor alpha and its ratio to soluble gp130: an additional mechanism for early increased bone resorption.
Dovio A; Perazzolo L; Saba L; Termine A; Capobianco M; Bertolotto A; Angeli A
Eur J Endocrinol; 2006 May; 154(5):745-51. PubMed ID: 16645023
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor.
Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J
J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364
[TBL] [Abstract][Full Text] [Related]
12. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing.
Ebihara N; Matsuda A; Nakamura S; Matsuda H; Murakami A
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8549-57. PubMed ID: 21989726
[TBL] [Abstract][Full Text] [Related]
13. Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts.
Spörri B; Müller KM; Wiesmann U; Bickel M
Int Immunol; 1999 Jul; 11(7):1053-8. PubMed ID: 10383937
[TBL] [Abstract][Full Text] [Related]
14. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
[TBL] [Abstract][Full Text] [Related]
15. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.
Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C
Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452
[TBL] [Abstract][Full Text] [Related]
16. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
[TBL] [Abstract][Full Text] [Related]
17. IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling.
Hoge J; Yan I; Jänner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrücker HW
J Immunol; 2013 Jan; 190(2):703-11. PubMed ID: 23241882
[TBL] [Abstract][Full Text] [Related]
18. IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer.
Lo CW; Chen MW; Hsiao M; Wang S; Chen CA; Hsiao SM; Chang JS; Lai TC; Rose-John S; Kuo ML; Wei LH
Cancer Res; 2011 Jan; 71(2):424-34. PubMed ID: 21123455
[TBL] [Abstract][Full Text] [Related]
19. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes.
Lee SY; Buhimschi IA; Dulay AT; Ali UA; Zhao G; Abdel-Razeq SS; Bahtiyar MO; Thung SF; Funai EF; Buhimschi CS
J Immunol; 2011 Mar; 186(5):3226-36. PubMed ID: 21282511
[TBL] [Abstract][Full Text] [Related]
20. The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin.
Marin V; Montero-Julian FA; Grès S; Boulay V; Bongrand P; Farnarier C; Kaplanski G
J Immunol; 2001 Sep; 167(6):3435-42. PubMed ID: 11544336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
